Kyoto Co-op supports the research on the new coronavirus vaccines

2020.07.30

At the 56th General Assembly of Kyoto Co-op, it was approved that a part of the surplus for the current financial period is set aside as "a contribution fund for the new coronavirus". Following the approval, Kyoto Co-op donated 10 million yen to The Institute for Frontier Life and Medical Sciences, Kyoto University.

kyoto-research-covid19-vaccines①.jpg
Mr.KOYANAGI Yoshio, the Director of the Institute for Frontier Life and Medical Sciences, Kyoto University (Left) 
Mr.HATA Tadao, the President of Kyoto Co-op (Right)

On June 15, 2020, after the Kyoto Co-op's General Assembly, a presentation ceremony was held in the meeting room of Co-op Gosho-Minami store where Mr. HATA Tadao, the President of Kyoto Co-op, presented an inventory representing the amount to Mr. KOYANAGI Yoshio, the Director of the Institute for Frontier Life and Medical Sciences, Kyoto University. Mr. HATA in his address stated, "We will continue to strengthen our contribution to the creation of a community where everyone can live with the sense of security." Director KOYANAGI Yoshio said, "We will make effective use of the donation to advance research and development of vaccines."
The new coronavirus is a virus that is unknown even among researchers, and research is still being conducted day and night to clarify it. At Kyoto Co-op, we hope that the donation will be used for therapeutic research that will lead to the development of new coronavirus vaccines and remedies.
Besides, Kyoto Co-op is calling for the "donation for the new coronavirus infection control measures" being implemented by Kyoto Prefecture in order to support healthcare professionals.

tags: a contribution fund for the new coronavirus, Kyoto Co-op